|Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021|
|New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology|
Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers.
Digital pathology solutions find the best fit in oncology care. According to WHO estimates, the number of new cases is expected to rise by about 70% over the next two decades. Digital pathology solutions are likely to be useful in cancer diagnosis, as these systems allow physicians to take and consider the second opinion on critical cases quickly. In addition, use of digital pathology in drug discovery enables pharmaceutical companies to remove bias and provide quantifiable results.
Click image to view it in full size